49 studies found for:    "Langerhans cell histiocytosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Intervention: Drug: methotrexate
2 Not yet recruiting LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Prednisone;   Drug: Vinblastine;   Drug: mercaptopurine;   Drug: INDOMETHACIN;   Drug: Methotrexate;   Drug: Cytosine Arabinoside;   Drug: 2-chlorodeoxyadenosine;   Procedure: hematopoietic stem cell transplantation (RIC-HSCT);   Biological: Intravenous immunoglobulin
3 Completed Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Condition: Childhood Langerhans Cell Histiocytosis
Interventions: Drug: leucovorin calcium;   Drug: methotrexate;   Drug: prednisolone;   Drug: vinblastine sulfate
4 Completed Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function
Condition: Pulmonary Langerhans Cell Histiocytosis
Intervention:
5 Active, not recruiting A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Intervention: Drug: GSK2110183
6 Recruiting Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis of Lung
Intervention: Drug: Cladribine
7 Completed Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis
Condition: Adult Pulmonary Langerhans Cell Histiocytosis
Intervention: Behavioral: Tabacco discontinuation
8 Terminated Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
Conditions: Adult Langerhans Cell Histiocytosis;   Childhood Langerhans Cell Histiocytosis;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Procedure: Peripheral Blood Stem Cell Transplantation
9 Terminated Macugen for Histoplasmosis
Conditions: Ocular Histoplasmosis;   Choroidal Neovascularization
Intervention: Drug: pegaptanib sodium
10 Completed Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs
Conditions: HIV Infections;   Histoplasmosis
Intervention:
11 Completed A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients
Conditions: HIV Infections;   Histoplasmosis
Intervention: Drug: Itraconazole
12 Completed A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
Conditions: HIV Infections;   Histoplasmosis
Intervention: Drug: Itraconazole
13 Completed A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS
Conditions: HIV Infections;   Histoplasmosis
Intervention: Drug: Itraconazole
14 Recruiting Treatment for Presumed Ocular Histoplasmosis
Condition: Ocular Histoplasmosis
Intervention: Drug: aflibercept
15 Completed Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome
Conditions: HIV Infections;   Histoplasmosis
Intervention: Drug: Fluconazole
16 Completed A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis
Conditions: HIV Infections;   Histoplasmosis;   Blastomycosis
Interventions: Drug: Itraconazole;   Drug: Amphotericin B
17 Unknown  Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis
Condition: Presumed Ocular Histoplasmosis (POHS)
Interventions: Drug: ranibizumab;   Drug: verteporfin
18 Unknown  Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
Condition: Ocular Histoplasmosis Syndrome
Intervention: Drug: ranibizumab
19 Not yet recruiting Clofarabine for Langerhans in Pedi
Condition: Langerhans Cell Histiocytosis
Intervention: Drug: Clofarabine
20 Active, not recruiting Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome
Conditions: Choroidal Neovascularization;   Presumed Ocular Histoplasmosis
Intervention: Drug: EYLEA (Aflibercept) intravitreal injection

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years